Initial evidence of the beneficial effects of glutamate-modulating agents in the treatment of self-injurious behavior associated with borderline personality disorder.
Pittenger
Christopher
C
Krystal
John H
JH
Coric
Vladimir
V
D000111:Acetylcysteine / Q000627:therapeutic use*; D000328:Adult; D001883:Borderline Personality Disorder / Q000188:drug therapy* / Q000523:psychology; D004359:Drug Therapy, Combination; D018691:Excitatory Amino Acid Antagonists / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D008875:Middle Aged; D019782:Riluzole / Q000627:therapeutic use*; D016728:Self-Injurious Behavior / Q000188:drug therapy* / Q000523:psychology; D016896:Treatment Outcome
D018691:Excitatory Amino Acid Antagonists; D019782:Riluzole; D000111:Acetylcysteine